Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0B3YW
|
||||
| Former ID |
DIB002431
|
||||
| Drug Name |
Isoquinoline alkaloids
|
||||
| Synonyms |
EM-011; EM-015; Isoquinoline alkaloids (tubulin binding); Isoquinoline alkaloids (tubulin binding), Emory University
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543674] | ||
| Company |
Emory University
|
||||
| Canonical SMILES |
c1(c2c(c(c3c1OCO3)OC)C(N(CC2)C)[C@H]1OC(=O)c2c(c(ccc12)<br />OC)OC)Br
|
||||
| Target and Pathway | |||||
| Target(s) | Tubulin beta | Target Info | Modulator | [543674] | |
| PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
| Huntington disease | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.